Cowealth Medical Holding (4745) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 合富-KY

Cowealth Medical Holding (4745) reported revenue of NT$183.7 million for Oct 2026, +12.5% year on year and -46.9% from the previous month. Revenue for Jan–Oct 2026 was NT$2.56 billion (+0.4% year on year).

In Oct 2026, it ranked No. 45 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$270.1 million24/10Nov 2024 NT$350.1 millionDec 2024 NT$404.1 millionJan 2025 NT$265.2 millionFeb 2025 NT$227.8 million25/02Mar 2025 NT$301.4 millionApr 2025 NT$322.6 millionMay 2025 NT$249.7 millionJun 2025 NT$246.2 million25/06Jul 2025 NT$239.2 millionAug 2025 NT$261 millionSep 2025 NT$271.4 millionOct 2025 NT$163.2 million25/10Nov 2025 NT$184.6 millionDec 2025 NT$271.3 millionJan 2026 NT$238.1 millionFeb 2026 NT$205.7 million26/02Mar 2026 NT$258.4 millionApr 2026 NT$287.5 millionMay 2026 NT$222.6 millionJun 2026 NT$343.8 million26/06Jul 2026 NT$245.5 millionAug 2026 NT$226.4 millionSep 2026 NT$345.7 millionOct 2026 NT$183.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$183.7 million+12.5%-46.9%
Sep 2026NT$345.7 million+27.4%+52.7%
Aug 2026NT$226.4 million-13.3%-7.8%
Jul 2026NT$245.5 million+2.6%-28.6%
Jun 2026NT$343.8 million+39.6%+54.5%
May 2026NT$222.6 million-10.9%-22.6%
Apr 2026NT$287.5 million-10.9%+11.3%
Mar 2026NT$258.4 million-14.3%+25.6%
Feb 2026NT$205.7 million-9.7%-13.6%
Jan 2026NT$238.1 million-10.2%-12.2%
Dec 2025NT$271.3 million-32.9%+46.9%
Nov 2025NT$184.6 million-47.3%+13.1%
Oct 2025NT$163.2 million-39.6%-39.9%
Sep 2025NT$271.4 million-32.1%+4.0%
Aug 2025NT$261 million-20.0%+9.1%
Jul 2025NT$239.2 million-23.3%-2.8%
Jun 2025NT$246.2 million-27.0%-1.4%
May 2025NT$249.7 million-23.7%-22.6%
Apr 2025NT$322.6 million-23.1%+7.0%
Mar 2025NT$301.4 million-23.0%+32.3%
Feb 2025NT$227.8 million-5.1%-14.1%
Jan 2025NT$265.2 million-36.1%-34.4%
Dec 2024NT$404.1 million-20.8%+15.4%
Nov 2024NT$350.1 million+10.4%+29.6%
Oct 2024NT$270.1 million-20.6%-32.4%

Jan–Oct 2026 cumulative: NT$2.56 billion (+0.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Cowealth Medical Holding vs PEC / Cowealth Medical Holding vs Lotus Pharm / Cowealth Medical Holding vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

公司2026年1-10月合併營業收入較去年同期增加0.38%,營收狀況改善。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16